Header Logo

Connection

RICHARD WELLS to Leukemia, Myelomonocytic, Chronic

Back to Details
This is a "connection" page, showing publications RICHARD WELLS has written about Leukemia, Myelomonocytic, Chronic.
RICHARD WELLS
Connection Strength
0.168
Leukemia, Myelomonocytic, Chronic
  1. Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study. Blood. 2020 08 06; 136(6):674-683.
    View in: PubMed
    Score: 0.168
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.